Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 379 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 1-25 of 101 matching filings.

Per page
25
Current page
1
8-K File 001-39126

CURRENT REPORT

Filing date
11 Mar 2026
Reporting date
11 Mar 2026
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
17 Dec 2025
Reporting date
16 Dec 2025
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
21 Nov 2025
Reporting date
17 Nov 2025
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
31 Mar 2025
Reporting date
31 Mar 2025
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
21 Feb 2025
Reporting date
19 Feb 2025
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
03 Jan 2025
Reporting date
03 Jan 2025
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
11 Dec 2024
Reporting date
11 Dec 2024
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
24 Oct 2024
Reporting date
23 Oct 2024
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
23 Oct 2024
Reporting date
23 Oct 2024
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
12 Sep 2024
Reporting date
10 Sep 2024
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
07 Aug 2024
Reporting date
06 Aug 2024
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
30 Jul 2024
Reporting date
30 Jul 2024
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
30 Jul 2024
Reporting date
29 Jul 2024
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
26 Jul 2024
Reporting date
26 Jul 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .